Summary
The purpose of this study was to analyze the components of inpatient costs for coronary artery bypass graft (CABG) according to preoperative risk stratification and to provide evidence for improvement of diagnosis-related groups (DRGs) payment. All patients (n=458) receiving an isolated CABG between January 2014 and December 2016 in a tertiary referral center, in southwest China, were analyzed. Hospital mortality was predicted by the EuroSCORE II for each patient. The patients were subdivided into two groups according to the observed mortality (1.97%, 9/458): a high-risk group (group H, predicted mortality ≥1.97%) and a low-risk group (group L, predicted mortality <1.97%). Clinical outcomes, resource use, in-hospital direct costs, and reimbursement expenses were compared between the two groups. Significant differences existed between group L and group H in postoperative mortality (0.4% vs. 3.4%; P=0.02), postoperative complications (10.6% vs. 45.7%; P<0.001), postoperative length of hospital stay (17.5±4.9 days vs. 18.8±6.5 days, P=0.01), in-hospital costs ($20 256±3096 vs. $23 334±6332; P<0.001), and reimbursement expenses ($7775±2627 vs. $9639±3917; P<0.001). In general, a higher EuroSCORE II was significantly associated with a worse clinical outcome and increased costs. The CABG cost data provide evidence for improvement of DRGs payment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gong P, Liang S, Carlton EJ, et al. Urbanisation and health in China. Lancet, 2012,379(9818):843–852
Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet, 2008,372(9650):1697–1705
Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation, 2014,129(14):1483–1492
Xi B, Liu F, Hao Y, et al. The growing burden of cardiovascular diseases in China. Int J Cardiol, 2014,174(3):736–737
Zhao C, Wang C, Shen C, et al. Diagnosis-related group (DRG)-based case-mix funding system, a promising alternative for fee for service payment in China. Bioscie Trends, 2018,12(2):109–115
Liu R, Shi J, Yang B, et al. Charting a path forward: policy analysis of China’s evolved DRG-based hospital payment system. Int Health, 2017,9(5):317–324
Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg, 2012,41(4):734–744; discussion 744-745
Ma X, Wang Y, Shan L, et al. Validation of SinoSCORE for isolated CABG operation in East China. Sci Rep, 2017,7(1):16806
Hogervorst EK, Rosseel PMJ, van de Watering LMG, et al. Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre. Neth Heart J. 2018, Sep.19. [Epub ahead of print] doi: 10.1007/s12471-018-1161-x
Osnabrugge RL, Speir AM, Head SJ, et al. Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg, 2013,96(2):500–506
Raza S, Sabik JF 3rd, Ainkaran P, et al. Coronary artery bypass grafting in diabetics: A growing health care cost crisis. J Thorac Cardiovasc Surg, 2015,150(2):304–2.e2
LaPar DJ, Rich JB, Isbell JM, et al. Preoperative Renal Function Predicts Hospital Costs and Length of Stay in Coronary Artery Bypass Grafting. Ann Thorac Surg, 2016,101(2):606–612
Getsios D, Wang Y, Stolar M, et al. Improved perioperative blood pressure control leads to reduced hospital costs. Expert Opin Pharmacother, 2013,14(10):1285–1293
Li X, Lu J, Hu S, et al. The primary health-care system in China. Lancet, 2017, 390(10 112):2584–2594
Mehaffey JH, Hawkins RB, Byler M, et al. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg, 2018,155(3):875–882e1
Osnabrugge RL, Speir AM, Head SJ, et al. Prediction of costs and length of stay in coronary artery bypass grafting. Ann Thorac Surg, 2014,98(4):1286–1293
Wu D, Yu F, Nie W. Improvement of the reduction in catastrophic L health expenditure in China’s public health insurance. PLoS One, 2018,13(4):e0194915
Silva GSD, Colosimo FC, Sousa AG, et al. Coronary Artery Bypass Graft Surgery Cost Coverage by the Brazilian Unified Health System (SUS). Braz J Cardiovasc Surg, 2017,32(4):253–259
Osnabrugge RL, Speir AM, Head SJ, et al. Cost, quality, and value in coronary artery bypass grafting. J Thorac Cardiovasc Surg, 2014,148(6):2729–2735e1
Yip WC, Hsiao WC, Chen W, et al. Early appraisal of China’s huge and complex health-care reforms. Lancet, 2012,379(9818):833–842
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yang, M., Hao, J., Jian, Z. et al. Effects of Preoperative Risk Stratification on Direct In-hospital Costs for Chinese Patients with Coronary Artery Bypass Graft: A Single Center Analysis. CURR MED SCI 38, 1075–1080 (2018). https://doi.org/10.1007/s11596-018-1986-y
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-018-1986-y